Related references
Note: Only part of the references are listed.Potentiation of Tumor Necrosis Factor-α-induced Tumor Cell Apoptosis by a Small Molecule Inhibitor for Anti-apoptotic Protein hPEBP4
Jianming Qiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel et al.
APOPTOSIS (2009)
Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis
Fang Yan et al.
GASTROENTEROLOGY (2009)
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Xin Lu et al.
GENES & DEVELOPMENT (2009)
ERK1/2 Mediate Wounding- and G-protein-Coupled Receptor Ligands-Induced EGFR Activation via Regulating ADAM17 and HB-EGF Shedding
Jia Yin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor
Richard E. Leach et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels
Catherine A. Tucker et al.
MOLECULAR CANCER THERAPEUTICS (2008)
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis
F. Revillion et al.
ANNALS OF ONCOLOGY (2008)
Maternal heparin-binding-EGF deficiency limits pregnancy success in mice
Huirong Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways
Giorgos Fitsialos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance
F. Wang et al.
ONCOGENE (2007)
Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent
Kenji Takeuchi et al.
FEBS JOURNAL (2006)
ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma
F Teralshi et al.
FEBS LETTERS (2005)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration
E Nishi et al.
EMBO JOURNAL (2001)
Share Paper
